Skip to content

Conventional Double-lumen Tube vs VivaSight DL

Ability of Anesthesiologist to Placid a Double-lumen Tube. A Randomized Crossover Cadaver Study Comparing VivaSight DL and Conventional Double-lumen Tube

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02741921
Enrollment
27
Registered
2016-04-18
Start date
2015-11-30
Completion date
2016-03-31
Last updated
2016-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endotracheal Intubation

Brief summary

The investigators sought to compare the time to intubation and success rate of the endotracheal intubation using standard double-lumen tube and video tube ETView DL in an adult cadaver model in normal and difficult airway conditions.

Interventions

DEVICEVivaSight DL

intubation using VivaSight DL tube

DEVICEconventional double-lumen tube

intubation using conventional double-lumen tube

Sponsors

Medical University of Warsaw
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* fresh adult cadavers

Exclusion criteria

* cadavers with face injures

Design outcomes

Primary

MeasureTime frameDescription
Time required for endotracheal intubation1 daytime from pick up the tube to first ventilation

Secondary

MeasureTime frameDescription
Time required for visual confirmation of double lumen tube position position1 dayTime required for visual confirmation of double lumen tube position position
success rate of intubation attempt1 daysuccess rate of first intubation attempt
Ease of intubation1 dayTo access subjective opinion about the difficulty of each intubation method, participants were asked to rate it on a visual analog scale (VAS) with a score from 1 (extremely easy) to 10 (extremely difficult).

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026